The field of gene editing is expanding rapidly. A team of scientists in China recently injected CRISPR-edited cells into a human patient for the first time — potentially setting off a biomedical race between China and the United States, as reported in the international scientific journal Nature.
More significant developments are expected in the years to come. The global CRISPR market is forecast to grow at an astonishing compound annual growth rate (CAGR) of 35% from 2016 to 2022, according to Inkwood Research, a market intelligence firm. The number of scientific papers published on CRISPR continues to soar, from below 200 papers in 2012 to more than 1,200 papers in 2015.
Increasing demand in drug discovery, late pregnancies leading to birth disorders, and aging genetic disorders are a few of the market drivers. The rise of genome editing is not without controversy, however. The possible misuse of CRISPR gene editing tools is an ongoing ethical concern and a restraint on the market.
In its newly published market research report, Inkwood Research identifies 16 major players in the CRISPR market:
According to the study, North America is the largest CRISPR market, but Asia Pacific is also a top region, especially given its applications in agriculture and animal breeding.
For in-depth analysis, competitive insights, and company profiles, check out the 135-page report on the global CRISPR market by Inkwood Research, which features 17 tables and 36 figures full of data. The report covers the regions of North America, Europe, and Asia Pacific and provides forecasts to 2022.
New to the concept of CRISPR? Learn the basics in our previously published blog post on CRISPR/Cas.
About the Author: Sarah Schmidt is a Managing Editor at MarketResearch.com, a leading provider of global market intelligence products and services.